Allogene Therapeutics (ALLO) EPS US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
EPS, rub ? -1.34 -2.38 -2.09 -1.32 -0.87   -0.72  
Changes by years, y/y, % -36% +77% -12% -37% -35%     -16.1%

Allogene Therapeutics. EPS, rub

Allogene Therapeutics. EPS, changes, %

Allogene Therapeutics (ALLO) EPS US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
EPS, rub ? -0.28 -0.23 -0.19 -0.18 -0.18   -0.72
Changes by years, y/y, % -28% -33% -41% -38% -36%    
Changes by quarters, q/q, % -3% -16% -20% -6% +1%    

Allogene Therapeutics. EPS, rub

Allogene Therapeutics. EPS, changes, y/y, %

Allogene Therapeutics. EPS, changes, q/q, %